(5-Cyclopropyl-1,3,4-thiadiazol-2-yl)methanol, 95%, 250mg

N-(4-Chloro-phenyl)-2-hydroxy-4-methyl-benzamide, 95.0%, 1g

2-(2-Fluoro-[1,1'-biphenyl]-4-yl)acetic acid, 95.0%, 250mg

2-(5-Fluoro-2-methoxyphenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 95.0%, 1g

3-Amino-2,2-dimethylpropanenitrile, 95%, 250mg

DIETHYL 2-(3-METHOXY-4-NITROPHENYL)MALONATE, 95.0%, 250mg

(S)-4-BOC-5-METHYL-1,4-DIAZEPANE, 95%, 5g

Methylene Glycol Bis(2,3-dibromopropyl) Ether>70.0%(GC)25mL

2,4-Diisopropoxybenzaldehyde, 10g

2-(2,5-Dimethylbenzyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 100mg

Pipetta per microlitri a canale singolo Pipetman® G, da 100 a 1000 µl, P1000G, 1 pezzo

Brivudine, 95.0%, 50mg

4-(2-(Dimethylamino)ethyl)aniline, 95.0%, 500mg